297 related articles for article (PubMed ID: 15296950)
21. Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006.
Fischer PM
Med Res Rev; 2007 Nov; 27(6):755-95. PubMed ID: 17019680
[TBL] [Abstract][Full Text] [Related]
22. Interaction of S413-PV cell penetrating peptide with model membranes: relevance to peptide translocation across biological membranes.
Mano M; Henriques A; Paiva A; Prieto M; Gavilanes F; Simões S; de Lima MC
J Pept Sci; 2007 May; 13(5):301-13. PubMed ID: 17437249
[TBL] [Abstract][Full Text] [Related]
23. Amphipathic peptides and drug delivery.
Fernández-Carneado J; Kogan MJ; Pujals S; Giralt E
Biopolymers; 2004; 76(2):196-203. PubMed ID: 15054899
[TBL] [Abstract][Full Text] [Related]
24. Cell-penetrating peptides in drug development: enabling intracellular targets.
Chen L; Harrison SD
Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156
[TBL] [Abstract][Full Text] [Related]
25. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
26. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
Mäe M; Langel U
Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
[TBL] [Abstract][Full Text] [Related]
27. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
Ziegler A
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
[TBL] [Abstract][Full Text] [Related]
28. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate.
Takeuchi T; Kosuge M; Tadokoro A; Sugiura Y; Nishi M; Kawata M; Sakai N; Matile S; Futaki S
ACS Chem Biol; 2006 Jun; 1(5):299-303. PubMed ID: 17163758
[TBL] [Abstract][Full Text] [Related]
29. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
30. Arginine-rich cell-penetrating peptides.
Schmidt N; Mishra A; Lai GH; Wong GC
FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
[TBL] [Abstract][Full Text] [Related]
31. The use of cell-penetrating peptides as a tool for gene regulation.
Järver P; Langel U
Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
[TBL] [Abstract][Full Text] [Related]
32. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
Zorko M; Langel U
Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162
[TBL] [Abstract][Full Text] [Related]
33. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Mäe M; Andaloussi SE; Lehto T; Langel U
Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
[TBL] [Abstract][Full Text] [Related]
34. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: a kinetic study followed by surface plasmon resonance.
Henriques ST; Castanho MA; Pattenden LK; Aguilar MI
Biopolymers; 2010; 94(3):314-22. PubMed ID: 20049920
[TBL] [Abstract][Full Text] [Related]
35. Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides.
Oehlke J; Lorenz D; Wiesner B; Bienert M
J Mol Recognit; 2005; 18(1):50-9. PubMed ID: 15386618
[TBL] [Abstract][Full Text] [Related]
36. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
Räägel H; Säälik P; Hansen M; Langel U; Pooga M
J Control Release; 2009 Oct; 139(2):108-17. PubMed ID: 19577599
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamics of lipid interactions with cell-penetrating peptides.
Sauder R; Seelig J; Ziegler A
Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
[TBL] [Abstract][Full Text] [Related]
38. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
Endoh T; Ohtsuki T
Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
[TBL] [Abstract][Full Text] [Related]
39. Properties of cell penetrating peptides (CPPs).
Kerkis A; Hayashi MA; Yamane T; Kerkis I
IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
